Revealing the heterogeneity of treatment resistance in less‐defined subtype diffuse large B cell lymphoma patients by integrating programmed cell death patterns and liquid biopsy

Abstract Precision medicine in less‐defined subtype diffuse large B‐cell lymphoma (DLBCL) remains a challenge due to the heterogeneous nature of the disease. Programmed cell death (PCD) pathways are crucial in the advancement of lymphoma and serve as significant prognostic markers for individuals af...

Descripció completa

Dades bibliogràfiques

Autors principals:	Wei Hua, Jie Liu, Yue Li, Hua Yin, Hao‐Rui Shen, Jia‐Zhu Wu, Yi‐Lin Kong, Bi‐Hui Pan, Jun‐Heng Liang, Li Wang, Jian‐Yong Li, Rui Gao, Jin‐Hua Liang, Wei Xu
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2025-01-01
Col·lecció:	Clinical and Translational Medicine
Matèries:	ctDNA DLBCL liquid biopsy lymphoma microenvironment machine learning prognostic nomogram
Accés en línia:	https://doi.org/10.1002/ctm2.70150
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!